HEPATIC IMPAIRMENT (HI)
Clinical trials for HEPATIC IMPAIRMENT (HI) explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT (HI) trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver health check: how does nemtabrutinib behave?
Knowledge-focused Recruiting nowThis study looks at how the drug nemtabrutinib is processed in the body of people with moderate liver impairment compared to healthy people. About 32 adults will take a single dose of the drug, and researchers will measure drug levels and safety. The goal is to understand if live…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated May 17, 2026 04:27 UTC
-
New drug tested in people with liver problems
Knowledge-focused Recruiting nowThis early-stage study looks at how a single dose of the experimental drug EDG-7500 is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. About 32 adults will participate to measure drug levels in the blood and che…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:13 UTC